急诊PCI治疗中应用替格瑞洛对STEMI患者微血管损伤及心功能的影响
[Abstract]:Objective to investigate the effect of tigrilol on microvascular injury and cardiac function in patients with ST segment elevation myocardial infarction (STEMI) treated with emergency PCI. Methods Eighty-five patients with PCI were randomly divided into two groups: tigrillo group (n = 44) and clopidogrel group (n = 41). Both groups were treated with emergency PCI. The maintenance dose of tigrilol was 90 mg/ d before operation in tigrello group, and 75 mg/ d / d in clopidogrel group before and after clopidogrel 600 mg,. Both groups were treated for 12 months. Microcirculation resistance index (IMR) was monitored immediately after operation in both groups. Mean Aortic pressure (Pd) of distal Coronary artery in (Pa), and mean conduction time of normal Saline flow under maximum congestive condition (Rest Tmn), calculation of Blood flow Reserve at rest of normal Saline flow (FFR), coronary flow reserve fraction (CFR) and IMR. Echocardiography was performed 24 hours after operation and 3 months after operation in both groups. End diastolic volume (EDV), end-systolic volume (ESV), left ventricular ejection fraction (LVEF) and wall motion index (WMSI).) were recorded. Results the Hyper Tmn,IMR of tigrilol group was lower than that of clopidogrel group (P 0. 05). There was no significant difference in Pa,Pd,Rest Tmn,FFR,CFR between the two groups (P 0. 05). The WMSI of the two groups at 3 months after operation was lower than that of the same group at 24 h (P. There was no significant difference in WMSI between the two groups at 3 months after operation (all P 0.05). There was no significant difference in EDV,ESV,LVEF between the two groups 24 hours after operation and 3 months after operation (P 0.05). Conclusion the application of tigrilol in emergency PCI treatment for STEMI patients is more helpful to alleviate microvascular injury and improve cardiac function than clopidogrel.
【作者单位】: 安徽医科大学附属省立医院;马鞍山市人民医院;
【基金】:安徽省国际科技合作计划项目(0908703042)
【分类号】:R542.22
【相似文献】
相关期刊论文 前8条
1 何作云;冠心病的微血管损伤研究进展[J];中国循环杂志;2003年05期
2 董姝;刘群;何艳丽;;STEMI患者急诊经皮冠状动脉介入术后抽吸血栓的组织病理学研究[J];中国动脉硬化杂志;2013年10期
3 崔广凯;;雷帕霉素药物洗脱支架在STEMI合并糖尿病患者急诊PCI中的应用[J];中国当代医药;2014年15期
4 蔡琦;;氯吡格雷和替罗非班联用对STEMI患者血小板功能及血小板表面受体表达影响的分析[J];医药论坛杂志;2011年09期
5 王宇平;张海滨;张学坤;郭金成;张立新;高国旺;张正海;;PCI后TIMI血流及心电图ST段在评价STEMI患者梗死区再灌注中的价值[J];山东医药;2011年29期
6 贾作飞;;急性ST段抬高心肌梗死(STEMI)溶栓后心律失常的监测与处理[J];中国社区医师(医学专业);2011年06期
7 杜秋波;柴建文;郝冬琴;王浩坤;李连东;武鑫玲;张朝华;张力俨;;急诊PCI术前应用盐酸替罗非班在STEMI中的临床研究[J];中国医药指南;2013年35期
8 王小维;贾大林;;STEMI患者PCI术后ST段演变的预后价值[J];临床心电学杂志;2014年01期
相关重要报纸文章 前1条
1 靖九江;心血管治疗研究获突破加用氯吡格雷可降低STEMI患者临床风险[N];中国医药报;2005年
相关博士学位论文 前2条
1 张丽娜;遗传变异与PCI术后冠心病患者临床预后的关系及多种遗传位点检测方法比较[D];华中科技大学;2015年
2 王浩然;CYP2C19*2基因型对氯吡格雷抗血小板聚集作用及体内活性代谢产物浓度的影响[D];华中科技大学;2015年
相关硕士学位论文 前5条
1 张阳阳;替格瑞洛与氯吡格雷治疗急性STEMI合并糖尿病患者的疗效及出血风险比较[D];郑州大学;2015年
2 傅颖;替格瑞洛和氯吡格雷对急诊介入治疗的STEMI患者炎症相关指标的影响[D];山东大学;2016年
3 孟杨;P2Y12抑制剂在接受DAPT治疗的氯吡格雷低反应性患者中的有效性及安全性评价[D];郑州大学;2017年
4 王书林;紫杉醇微盲孔载药支架与雷帕霉素涂层支架在STEMI直接经皮冠状动脉介入治疗中应用的对比研究[D];天津医科大学;2011年
5 刘长红;不同干预措施对STEMI无复流治疗效果观察[D];天津医科大学;2013年
,本文编号:2217181
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2217181.html